The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice

Matthew L Kelso1, Jeanne M Wehner, Allan C Collins

  • 1College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.

Brain Research
|March 21, 2006
PubMed

Insights

Traumatic brain injury (TBI) decreases alpha7 nicotinic receptor binding. Genetically depleting alpha7 nicotinic acetylcholine receptors (nAChRs) in mice did not alter brain inflammation or tissue loss following TBI, suggesting compensatory mechanisms may be involved.

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Neuroinflammation

Background:

  • Alpha7 nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels implicated in traumatic brain injury (TBI) pathophysiology.
  • Previous studies show TBI decreases alpha7 nAChR binding in rats, suggesting a role in cognitive impairment.

Purpose of the Study:

  • To investigate if genotypic depletion of alpha7 nAChRs influences sensitivity to tissue loss and brain inflammation post-TBI.
  • To determine if reduced alpha7 nAChR expression impacts TBI outcomes.

Main Methods:

  • Wild-type, heterozygous, and null mutant mice were subjected to a cortical contusion injury.
  • Brain inflammation, nicotinic receptor expression, and cortical tissue sparing were assessed one week post-TBI.

Main Results:

  • TBI significantly decreased alpha-[(125)I]-bungarotoxin (BTX) binding in wild-type mouse hippocampus, confirming previous findings.
  • No genotypic differences in cortical tissue sparing or brain inflammation were observed between wild-type, heterozygous, and null mutant mice.

Conclusions:

  • Genotypic depletion of alpha7 nAChRs did not alter TBI-induced tissue loss or inflammation in this model.
  • Compensatory mechanisms in null mutant mice may confound results, and the role of alpha7 nAChRs in TBI pathophysiology warrants further investigation.

Related Concept Videos